| Name | Title | Contact Details |
|---|
OSCOR Inc. designs, develops, manufactures and markets a variety of highly specialized implantable cardiac pacing leads, venous access systems and diagnostic catheters. Oscor is also leveraging its proprietary lead technologies toward the development
WCCT Global is a multi-site, full service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, “With compassion for people, we strive for tomorrow’s therapies to be available today” truly exemplifies the focus and reason for our cutting edge work both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory, program management, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines.
NutraClick is a technology-driven health and wellness products company committed to enriching consumers’ lives. The company’s award-winning brands include Force Factor, Peak Life, Stages of Beauty, Bona Clara, Femme Factor, and ProbioSlim. Headquartered in Boston, Mass., NutraClick leverages the power of online marketing to drive multi-channel demand. NutraClick products are available online and in more than 30,000 retail locations globally, including GNC, CVS and Walmart. For additional information, please visit www.nutraclick.com and follow us on Twitter.
The HealthMyne Quantitative Imaging Decision Support (QIDS)® software platform and its Rapid Precise Metrics (RPM)™ functionality transform multiple clinical decision support workflows by combining quantitative imaging metrics with relevant patient information.
Founded in May 2020 by Dr. Kimon Angelides and publicly launched in October 2021, FemTec Health is the leading Health and Beauty Sciences Company focused on women`s health. Angelides has brought together a female-led team with decades of experience across healthcare, wellness, and consumer products in public and private companies. FemTec Health`s mission is to revolutionize women`s healthcare by using state-of-the-art genomics, predictive intelligence, and digital technologies to create an experience that is unified, coordinated, and provides personalized services and products that are meaningful and effective for women. With offices in Houston, New York, San Diego, London, Barcelona, Athens & Shanghai. FemTec Health currently has over 150 employees and is growing rapidly. Investors, capital and shareholders include Longmont Capital, Ltd and HellasMed, LLC (company principals), Walgreens, Trinity, Unilever Ventures.